Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by Mugen1996on Apr 24, 2008 7:19pm

192 Views

Post# 15007434

Volume

I think we are not getting use to see these low volume on this stock. This probably mean that people are waiting aside for something to happen. As soon as we will see a huge Cross on the ask this thing will move again. Let's hope we can hold at this level.... because shorters will be back again if this thing breaks 7.50$

Is the final chapter of this story will be unfold in May? I hope so!

L8r

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute